Desulfovibrio

H2S Production and Toxicity#

Desulfovibrio uses sulfate as a terminal electron acceptor in anaerobic respiration, reducing it to H2S via dissimilatory sulfate reduction. H2S toxicity mechanisms in the gut.

Cytochrome c oxidase inhibition: H2S blocks the terminal enzyme of colonocyte mitochondrial oxidative phosphorylation, starving epithelial cells of energy—analogous to cyanide poisoning at the cellular level.

Barrier disruption: energy-depleted colonocytes lose tight junction integrity, increasing gut permeability and enabling bacterial translocation. DNA damage: H2S generates reactive sulfur species and free radicals that cause genotoxic damage to colonocytes, contributing to Colorectal Cancer initiation.

NF-kB activation: H2S activates NF-kB inflammatory signaling in epithelial and immune cells, driving chronic inflammation.

H2S competes with Butyrate for colonocyte energy metabolism: when H2S levels rise and butyrate levels fall (due to depletion of Roseburia, Faecalibacterium prausnitzii), colonocytes shift from oxidative to glycolytic metabolism, further destabilizing the anaerobic gut environment.

Metal Dependencies#

Iron: Iron-sulfur clusters are central to the dissimilatory sulfate reduction pathway. Desulfovibrio requires substantial iron for its [iron (Fe)] Hydrogenase and ferredoxin electron carriers. Nickel: Some species possess [NiFe]-hydrogenase for hydrogen-dependent sulfate reduction, linking their metabolism to Nickel availability in the gut.

Molybdenum: Certain sulfate reductases use Molybdenum cofactors.

Mercury: Desulfovibrio species are enriched by Mercury exposure in the gut, and some SRB can methylate inorganic mercury to neurotoxic methylmercury.^{[1]Rezazadegan et al. 2025 — Heavy Metals and Gut Microbiota: A Systematic ReviewFatemeh Rezazadegan, Maryam Mahmoudi, Seyed Mohammad Mousavi · 2025Open reference 1 ↓}

Disease Associations#

Endometriosis: H2S/NF-kB pathway activation promotes endometrial inflammation and lesion progression. Desulfovibrio enrichment may contribute to the inflammatory milieu driving Endometriosis.

Cardiovascular disease: enriched in CVD; H2S can promote atherosclerotic plaque instability. Spermidine supplementation paradoxically increases Desulfovibrionaceae while improving cardiovascular outcomes, suggesting dose-dependent or context-dependent H2S effects.^{[2]The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?Catia Almeida, J. Guilherme Goncalves-Nobre, Diogo Alpuim Costa et al. · 2023Open reference 2 ↓}

Colorectal cancer: H2S-mediated DNA damage and NF-kB activation contribute to carcinogenesis. Desulfovibrio showed opposite directionality—increased in cancer, decreased in autoimmune disease.^{[3]Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysisMd Zohorul Islam, Melissa Tran, Tao Xu et al. · 2022Open reference 3 ↓}

Parkinson's disease: enriched in PD gut; H2S may compound mitochondrial dysfunction in the enteric nervous system. Bilophila wadsworthia (related SRB): metabolizes taurine-conjugated bile acids to produce H2S, linking high-fat diet (which increases taurine-conjugated bile acids) to sulfide-driven inflammation.

H2S as a Double-Edged Sword#

At physiological concentrations, H2S is a gasotransmitter with anti-inflammatory and cytoprotective effects (similar to NO and CO). At supraphysiological concentrations produced by Desulfovibrio overgrowth, H2S becomes cytotoxic and pro-inflammatory. This dose-response relationship complicates therapeutic targeting: complete elimination of SRB would remove physiological H2S signaling.

Key Metabolites#

Hydrogen sulfide (H2S)—primary output; cytochrome c oxidase inhibitor, DNA damaging agent, NF-kB activator. Acetate—secondary fermentation product from incomplete oxidation of organic substrates. Methylmercury—some species convert inorganic mercury to neurotoxic methylmercury (MeHg).